Escientia Life Sciences Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Escientia Life Sciences's estimated annual revenue is currently $23.5M per year.(i)
  • Escientia Life Sciences's estimated revenue per employee is $201,000

Employee Data

  • Escientia Life Sciences has 117 Employees.(i)
  • Escientia Life Sciences grew their employee count by -2% last year.

Escientia Life Sciences's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Co-Founder and PresidentReveal Email/Phone
3
Associate VP for AnalyticalReveal Email/Phone
4
Group Chief Financial OfficerReveal Email/Phone
5
ManagerReveal Email/Phone
6
Manager HR & Admin (Site HR Head)Reveal Email/Phone
7
ManagerReveal Email/Phone
8
General Manager - Projects & Process EngineeringReveal Email/Phone
9
Senoir managerReveal Email/Phone
10
Quality Assurance ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$151.8M75511%N/AN/A
#6
$63.9M31813%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$1.7M17-6%$114.3MN/A
#9
$6.8M34-6%N/AN/A
#10
$12.5M62-9%N/AN/A
Add Company

What Is Escientia Life Sciences?

Modern science and engineering are revolutionizing the way medicines are made. Continuous processes, greener chemistry, and reliability are the core themes of twenty-first century biopharma manufacturing. Our mission is to be the invaluable technolgy-oriented manufacturing partner of the world's largest and most innovative pharmaceutical and biotechnology companies. We endeavor to be a socially useful business by playing a meaningful role in lowering the cost and quickening the speed to market of life-saving therapeutics.

keywords:N/A

N/A

Total Funding

117

Number of Employees

$23.5M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.1M1178%N/A
#2
$29.6M11729%N/A
#3
$11.7M11716%N/A
#4
$31.6M117-6%N/A
#5
$21.1M11715%N/A